NIEMANN-PICK TYPE C DISEASE
Clinical trials for NIEMANN-PICK TYPE C DISEASE explained in plain language.
Never miss a new study
Get alerted when new NIEMANN-PICK TYPE C DISEASE trials appear
Sign up with your email to follow new studies for NIEMANN-PICK TYPE C DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare childhood brain disease: major trial tests first oral treatment
Disease control Recruiting nowThis study is testing whether a daily oral medication called nizubaglustat can safely slow the progression of Niemann-Pick Type C (NPC), a rare and severe genetic disorder that affects the brain. It will involve about 72 children and young people (ages 4+) with NPC over 18 months…
Matched conditions: NIEMANN-PICK TYPE C DISEASE
Phase: PHASE3 • Sponsor: Azafaros A.G. • Aim: Disease control
Last updated Apr 02, 2026 02:56 UTC
-
New drug offers hope for families battling rare, devastating brain diseases
Disease control Recruiting nowThis study aims to gather long-term safety and effectiveness data for the drug nizubaglustat in people with rare, progressive brain disorders (GM2 gangliosidosis or Niemann-Pick type C). It includes two groups: patients continuing from a previous study and patients switching from…
Matched conditions: NIEMANN-PICK TYPE C DISEASE
Phase: PHASE2 • Sponsor: Azafaros A.G. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for kids with devastating rare brain diseases
Disease control Recruiting nowThis study is testing whether an oral drug called nizubaglustat can safely slow down or control the progression of several rare, inherited brain diseases in children. It will involve about 147 participants, aged 4 and older, who have conditions like Niemann-Pick Type C or GM1/GM2…
Matched conditions: NIEMANN-PICK TYPE C DISEASE
Phase: PHASE3 • Sponsor: Azafaros A.G. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC